Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Breast 3Other 2Genitourinary 2Tumor-Agnostic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Urologic Neoplasms 1Urologic Diseases 1Urolithiasis 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Non-Muscle Invasive Bladder Neoplasms 1Hydronephrosis 1Carcinoma, Transitional Cell 1

Interventions

Docetaxel 205Prednisone 151enzalutamide 128Gemcitabine 123Radiotherapy 116Sunitinib 112Cisplatin 103Leuprolide 98pembrolizumab 96Abiraterone Acetate 94bicalutamide 87Nivolumab 85Goserelin 83Sorafenib 80Paclitaxel 79Carboplatin 77Everolimus 72Bevacizumab 71Magnetic Resonance Spectroscopy 66acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 61pazopanib 56radium Ra 223 dichloride 50Ipilimumab 49Zoledronic Acid 47Radiosurgery 43Cyclophosphamide 43Filgrastim 42abiraterone 41gallium 68 PSMA-11 40Surveys and Questionnaires 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Water × Genitourinary × Clear all
NCT03794102 2019-01-04

Water Versus Saline as Irrigation Fluid for Ureteroscopy

Emory University

Phase NA Completed
150 enrolled
Genitourinary

Carcinoma, Transitional Cell, Hydronephrosis, Urolithiasis

NCT01803295 2017-06-16

OPTIMA

UroGen Pharma Ltd.

Phase NA Completed
80 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡